Publikace
- Reduction of the Potential Anticancer Drug Oracin in the Rat Liver In vitro2000 | Farmaceutická fakulta v Hradci Králové
- The Main Metabolic Pathway of Oracin, a New Potential Cytostatic Drug, in Human Liver Microsomes and Cytosol: Stereoselectivity of Reoxidation of the Principal Metabolite 11-Dihydrooracin to Oracin2000 | Farmaceutická fakulta v Hradci Králové
- Methods for the detection and characterization of metabolites of the potential cytostatic drug oracine1998 | Farmaceutická fakulta v Hradci Králové
- Biotransformation of potential cytostatic drug oracin1998 | Farmaceutická fakulta v Hradci Králové
- High-performance liquid chromatography study of stereospecific microsomal enzymes catalysing the reduction of a potential cytostatic drug, oracin. Interspecies comparison1998 | Farmaceutická fakulta v Hradci Králové
- Interspecies differences in chiral metabolism of the potential cytostatic drug - Oracin1997 | Farmaceutická fakulta v Hradci Králové, Ústřední knihovna
- Reductive biotransformation of the potential cytostatic drug oracin at chiral level in rats in vitro and in vivo1997 | Farmaceutická fakulta v Hradci Králové
- Studies on the metabolism of the potential cytostatic drug oracine. Species differences +11996 | Farmaceutická fakulta v Hradci Králové
- High-performance liquid chromatographic assay for separation and characterization of metabolites of the potential cytostatic drug oracine1996 | Farmaceutická fakulta v Hradci Králové
- Preliminary study for the separation of optically active metabolites of potentional cytostatic drug - oracine using HPLC1995 | Farmaceutická fakulta v Hradci Králové
Loading network view...